Health and Human Services Secretary Robert F. Kennedy Jr. is overseeing efforts to examine reports of adverse events, including deaths, linked to COVID-19 vaccines among active-duty service members. This review builds on prior Department of Defense studies required by the 2024 National Defense Authorization Act.

The Pentagon has previously documented modest increases in conditions such as myocarditis and pericarditis following vaccination in some analyses of service members. A DoD report released earlier this year assessed health outcomes one year after the first dose and noted consistency with known rare side effects while also highlighting data on other conditions.

Kennedy, who has limited COVID-19 vaccine recommendations to older adults and those with underlying conditions, has emphasized transparency on vaccine safety. Federal reviews under his department have included analyses of Vaccine Adverse Event Reporting System data, with attention to cardiac issues.

Thousands of troops were separated for refusing the vaccine before the mandate ended in 2023. Recent Pentagon updates indicate more than 230 have rejoined under reinstatement policies, with additional service members expressing interest. Defense officials have also announced plans to convene a panel to study the original mandate decision and release related materials.

Critics of the mandate have pointed to database concerns and individual reports of health impacts. Supporters of the review argue it addresses legitimate questions about causation and long-term effects in a young, healthy population.

The effort aligns with broader policy shifts at HHS to reassess mRNA vaccine oversight and recommendations. No final conclusions on troop deaths have been released as part of this specific military-focused examination.